Richard Macdonell's Profile

Role	Title	Level	Year	L/R
🐢	Leadership for Competitive Advantage N. Georgiades, Richard Macdonell	5	1998	5 🐢
🐜	Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. 60 auth. T. Kalincik, S. Sharmin, I. Roos, M. Freedman, H. Atkins, J. Burman, J. Massey, I. Sutton, Barbara Withers, Richard Macdonell, A. Grigg, Ø. Torkildsen, L. Bø, A. K. Lehmann, E. Havrdová, ... E. Krasulová, M. Trněný, T. Kozák, A. van der Walt, H. Butzkueven, P. Mccombe, O. Skibina, J. Lechner-Scott, B. Willekens, E. Cartechini, S. Ozakbas, R. Alroughani, J. Kuhle, F. Patti, P. Duquette, A. Lugaresi, S. Khoury, M. Slee, R. Turkoglu, S. Hodgkinson, N. John, D. Maimone, M. Sá, V. van Pesch, O. Gerlach, G. Laureys, L. Van Hijfte, R. Karabudak, D. Spitaleri, T. Csépány, R. Gouider, T. Castillo-Triviño, B. Taylor, B. Sharrack, J. Snowden, S. Mrabet, J. Garber, J. Sánchez-Menoyo, E. Aguera-Morales, Y. Blanco, A. Al-Asmi, B. Weinstock-Guttman, Y. Fragoso, K. de Gans, A. Kermode	4	2023	4 🐜
🐜	Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis 92 auth. C. Daruwalla, V. Shaygannejad, S. Ozakbas, E. Havrdová, D. Horáková, R. Alroughani, C. Boz, F. Patti, M. Onofrj, A. Lugaresi, S. Eichau, M. Girard, A. Prat, P. Duquette, B. Yamout, ... S. Khoury, S. Sajedi, R. Turkoglu, A. Altıntaş, O. Skibina, K. Buzzard, P. Grammond, R. Karabudak, A. van der Walt, H. Butzkueven, D. Maimone, J. Lechner-Scott, A. Soysal, N. John, J. Prevost, D. Spitaleri, C. Ramo-Tello, O. Gerlach, G. Iuliano, M. Foschi, R. Ampapa, V. van Pesch, M. Barnett, N. Shalaby, M. D'hooghe, J. Kuhle, M. Sá, M. Fabis-Pedrini, A. Kermode, S. Mrabet, R. Gouider, S. Hodgkinson, G. Laureys, L. Van Hijfte, Richard Macdonell, C. Oreja-Guevara, E. Cristiano, P. Mccombe, J. Sánchez-Menoyo, B. Singhal, Y. Blanco, S. Hughes, J. Garber, C. Solaro, C. McGuigan, B. Taylor, K. de Gans, M. Habek, A. Al-Asmi, S. Mihaela, T. Castillo Triviño, T. Al-Harbi, J. Rojas, O. Gray, D. Khurana, B. Van Wijmeersch, N. Grigoriadis, J. Inshasi, Jiwon Oh, E. Aguera-Morales, Y. Fragoso, F. Moore, C. Shaw, S. Baghbanian, N. Shuey, B. Willekens, T. Hardy, D. Decoo, Á. Sempere, Deborah Field, R. Wynford-Thomas, N. Cunniffe, I. Roos, C. Malpas, A. Coles, T. Kalincik, J. W. Brown	3	2023	3 🐜
🐜	Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome 28 auth. H. Butzkueven, A. Ponsonby, Mark S Stein, Robyn M Lucas, Deborah Mason, S. Broadley, Trevor Kilpatrick, J. Lechner-Scott, Michael Barnett, William Carroll, Peter Mitchell, Todd Hardy, Richard Macdonell, P. Mccombe, Andrew Lee, ... T. Kalincik, A. van der Walt, Chris Lynch, David Abernethy, Ernie Willoughby, F. Barkhof, D. MacManus, Michael Clarke, Julie Andrew, Julia Morahan, Chao Zhu, K. Dear, B. Taylor	3	2023	3 🐜
🐜	Prevalence, risk factors, and prognosis of drug-resistant epilepsy in autoimmune encephalitis 14 auth. R. Wesselingh, J. Broadley, K. Buzzard, D. Tarlinton, U. Seneviratne, Chris Kyndt, J. Stankovich, Paul G. Sanfilippo, Cassie Nesbitt, W. D'Souza, ... Richard Macdonell, H. Butzkueven, Terence J. O’Brien, Mastura Monif	3	2022	3 🐜
🐜	Dominant NARS1 mutations causing axonal Charcot-Marie-Tooth disease expand NARS1-associated diseases. 17 auth. Danique Beijer, Sheila Marte, Jiaxin C Li, W. De Ridder, Jessie Z Chen, Abigail L D Tadenev, Kathy E. Miers, T. Deconinck, Richard Macdonell, Wilson Marques, ... P. de Jonghe, S. L. Pratt, Rebecca Meyer-Schuman, S. Züchner, A. Antonellis, R. W. Burgess, J. Baets	3	2024	3 🐜